MARAVAI LIFESCIENCES HLDGS I's ticker is MRVI and the CUSIP is 56600D107. A total of 234 filers reported holding MARAVAI LIFESCIENCES HLDGS I in Q1 2022. The put-call ratio across all filers is 0.26 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $862 | -92.9% | 86,107 | -91.2% | 0.00% | -100.0% |
| Q2 2023 | $12,130 | -11.2% | 975,770 | +0.1% | 0.00% | 0.0% |
| Q1 2023 | $13,657 | -1.7% | 974,740 | +0.4% | 0.00% | 0.0% |
| Q4 2022 | $13,888 | -100.0% | 970,525 | -25.3% | 0.00% | -60.0% |
| Q3 2022 | $33,174,000 | -29.1% | 1,299,365 | -21.1% | 0.01% | -16.7% |
| Q2 2022 | $46,809,000 | -35.2% | 1,647,627 | -19.6% | 0.01% | -14.3% |
| Q1 2022 | $72,267,000 | -11.4% | 2,048,957 | +5.3% | 0.01% | 0.0% |
| Q4 2021 | $81,568,000 | +8.7% | 1,946,736 | +27.4% | 0.01% | 0.0% |
| Q3 2021 | $75,020,000 | +110.9% | 1,528,533 | +79.3% | 0.01% | +133.3% |
| Q2 2021 | $35,578,000 | +198.3% | 852,582 | +154.7% | 0.00% | +200.0% |
| Q1 2021 | $11,928,000 | – | 334,689 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GTCR LLC | 21,681,033 | $1,064,105,000 | 26.99% |
| Ghisallo Capital Management LLC | 1,250,000 | $61,350,000 | 2.33% |
| Beck Bode, LLC | 160,064 | $7,856,000 | 2.19% |
| Select Equity Group, L.P. | 12,122,011 | $594,948,300,000 | 2.00% |
| Pinz Capital Management, LP | 83,603 | $4,103,000 | 1.86% |
| Monashee Investment Management LLC | 185,000 | $9,080,000 | 1.68% |
| Ownership Capital B.V. | 2,717,559 | $133,378,000 | 1.51% |
| Eversept Partners, LP | 327,810 | $16,088,915 | 1.12% |
| Parkman Healthcare Partners LLC | 90,000 | $4,417,000 | 1.12% |
| Connacht Asset Management LP | 28,569 | $1,402,000 | 0.91% |